Research on vaccine regimens against SARS-CoV-2 has shown promising results, with certain combinations inducing robust and durable immune responses. Studies have explored the immunogenicity of various vaccine candidates, including those based on modified vaccinia Ankara (MVA) and DNA-launched RNA replicon vaccines. The effectiveness of these vaccine regimens in humans and animals, including the potential for boosting immune responses, is being investigated.